Loading

Panel: From discovery to development – Creating realistic CGT timelines

03 Sep 2025
Theatre 2
Manufacturing, scale up & commercial strategy
  • Transitioning from academic proof of concept to first-in-human

  • Why biotech teams must integrate CMC, regulatory and pharmacology early 

  • Avoiding pitfalls of overselling and overpromising 

Chairperson
Andrew Frazer, Associate Director, Scientific Solutions - Charles River Laboratories
Speakers
Anne Douar, Principal & Founder - Ad hoc Biologics
Alessandra Magnani, Head of the Advanced Therapies and Immunotherapy Platform - Hospital Sant Joan de Déu 
Claudio Santos, CEO - Gyala Therapeutics
Elena Matsa, Professor - University College Cork
Charles River Logo